Spinocerebellar Ataxia 29

Also Known As:

Aplasia of cerebellar vermis; Cerebellar ataxia, congenital, nonprogressive, autosomal dominant; Cerebellar ataxia, early-onset, nonprogressive; Cerebellar vermis aplasia; SCA29 Spinocerebellar Ataxia 29

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Nervous System Diseases: 14178
- Neurodegenerative Diseases: 42472
  - Nervous System Heredodegenerative Disorders: 63
    - Spinocerebellar Degenerations: 353
      - Spinocerebellar Ataxia 29: 1
- Central Nervous System Diseases: 4213
  - Brain Diseases: 15694
    - Cerebellar Diseases: 631
      - Spinocerebellar Degenerations: 353
        Spinocerebellar Ataxia 29: 1
  - Spinal Cord Diseases: 4314
    - Spinocerebellar Degenerations: 353
      - Spinocerebellar Ataxia 29: 1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Inborn Genetic Diseases: 11939
  - Nervous System Heredodegenerative Disorders: 63
    - Spinocerebellar Degenerations: 353
      - Spinocerebellar Ataxia 29: 1

Experts

1.	Ando, Hideaki: 1 article (11/2018)
2.	Hirose, Matsumi: 1 article (11/2018)
3.	Mikoshiba, Katsuhiko: 1 article (11/2018)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Spinocerebellar Ataxia 29:

1.	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 11/27/2018 - "Aberrant IP3 receptor activities revealed by comprehensive analysis of pathological mutations causing spinocerebellar ataxia 29."